Robocath completes first-in-human study enrollment for next-generation PCI robotic system
The clinical study in France evaluated the safety and feasibility of Robocath’s robotic-assisted coronary intervention platform across complex cardiac cases.
The clinical study in France evaluated the safety and feasibility of Robocath’s robotic-assisted coronary intervention platform across complex cardiac cases.
The hospital chain reported strong growth driven by its Gurugram facility, international patient inflow, and operational efficiencies
Clinical guidelines and expert consensus recommend 1.2–1.5 g/kg/day protein intake during therapy to help preserve muscle mass
The acquisition positions Roche more aggressively in digital pathology and precision diagnostics capabilities
The deal positions MilliporeSigma at the center of commercial manufacturing for three breakthrough gene therapies targeting sickle cell disease, ?-thalassemia, and cerebral adrenoleukodystrophy
The facility combines advanced diagnostics, bone marrow transplant evaluation, prenatal awareness, and multidisciplinary support services
The acquisition gives Bayer full rights to PER-001, an experimental therapy now in Phase II clinical trials for Glaucoma and Diabetic Retinopathy
Company handles 20,000+ AI-driven calls and chats daily as it scales agentic AI systems across healthcare workflows
Complex tumour removed in a young patient without major pancreatic loss, reducing risk of lifelong diabetes
The initiative by DKMS Foundation India is for below 12 years children suffering from transfusion-dependent thalassemia
Subscribe To Our Newsletter & Stay Updated